Article

CANADA CANNABIS INVESTMENT SERIES - Part Four

November 14, 2018

 

 

As announced last week, four significant Canada focused public cannabis companies are to report earnings and issue other reports, especially post-legalization commentaries --- Aurora Cannabis Inc., Tilray Inc.,  Cronos Group Inc., and Canopy Growth Corp. Today’ public company review is Canopy Growth Corp.

 

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, soft gel capsules, and hemp. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

 

Canopy Growth Corporation (CGC) 38.48

 

Earnings report:  Canopy Growth reports Q2 (Sep) results, misses on revs. Reports Q2 (Sep) loss of CAD $1.52 per share, may not be comparable to the single analyst estimate of (CAD $0.10); revenues rose 32.4% year/year to CAD $23.3 mln vs the CC$59.1 mln S&P Capital IQ Consensus.

 

Overview:  During the second quarter of fiscal 2019 ended September 30, 2018, the Company sold 2,197 kilograms and kilogram equivalents at an average sale price of $9.87, up from 2,020 kilograms and kilogram equivalents at an average price of $7.99 in the prior year period, representing an increase of 9% and 24% respectively. Adjusted EBITDA in the second quarter fiscal 2019 amounted to a loss of $57.7 million compared to a loss of $4.8 million in the same period last year. Other expenses of $115.7 million are primarily made up of fair value changes on financial assets and financial liabilities, the majority of which is non-cash. The $115.7 million in other expenses described above, accounted for $0.52 of the reported $1.52 loss per basic and diluted share in the quarter, compared to net loss of $0.01 per basic and diluted share in the comparative period last year.

 

Commentary:  The growing, possession, and sale of medical cannabis is not a long-term business model to warrant further investment commitment. If you purchased CGC in the $20 range (near the 52 week low) as suggested, the current value should be a good reason to a SELL.  With a market capitalization of $11.59 billion (that’s right BILLION), and leveraged Free Cash Flow $  -234.94 million, CGC is overpriced and overextended. It is a business model that will not work in the current environment.

 

Valuation Measures

Market Cap (intraday)    11.59B

Enterprise Value    7.93B

Trailing P/E     N/A

Forward P/E     N/A

PEG Ratio (5 yr expected) 1    N/A

Price/Sales (ttm)    175.21

Price/Book (mrq)    8.08

Enterprise Value/Revenue     119.83

Enterprise Value/EBITDA     -126.65

 

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends     Mar 30, 2018

Most Recent Quarter (mrq)    Jun 29, 2018

 

Profitability

Profit Margin     -160.90%

Operating Margin (ttm)    -118.53%

Management Effectiveness

Return on Assets (ttm)    -4.57%

Return on Equity (ttm)    -14.25%

Income Statement

Revenue (ttm)    66.14M

Revenue Per Share (ttm)    0.35

Quarterly Revenue Growth (yoy)    63.30%

Gross Profit (ttm)    74.19M

EBITDA     -62.58M

Net Income Avi to Common (ttm)    -106.43M

Diluted EPS (ttm)    -0.5710

Quarterly Earnings Growth (yoy)    N/A

 

Balance Sheet

Total Cash (mrq)    494.55M

Total Cash Per Share (mrq)    2.45

Total Debt (mrq)    466.28M

Total Debt/Equity (mrq)    50.66

Current Ratio (mrq)    6.84

Book Value Per Share (mrq)    4.24

Cash Flow Statement

Operating Cash Flow (ttm)    -102.8M

Levered Free Cash Flow (ttm)    -234.94M

 

Trading Information

Stock Price History

Beta (3Y Monthly)     2.43

52-Week Change     ∞%

S&P500 52-Week Change     5.56%

52 Week High     59.25

52 Week Low     16.74

50-Day Moving Average     44.65

200-Day Moving Average     35.81

 

Share Statistics

Avg Vol (3 month)     15.49M

Avg Vol (10 day)     13.67M

Shares Outstanding     201.55M

Float     123.77M

% Held by Insiders    N/A

% Held by Institutions     N/A

Shares Short (Oct 30, 2018)     16.06M

Short Ratio (Oct 30, 2018)     1.19

Short % of Float (Oct 30, 2018)     N/A

Short % of Shares Outstanding (Oct 30, 2018)     7.21%

Shares Short (prior month Sep 27, 2018)     13.83M

 

Please reload

Recent Posts

December 13, 2019

December 4, 2019

Please reload

Archive

Please reload

Tags

Please reload

Legal | Privacy

©2019 by first jersey cannabis corp.